Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadashi Watabe

Showing results (121-130 of 185) with videos related to

Pageof 19
Sort By:
Oncotarget|April 29, 2020
Targeted alpha therapy using astatine (<sup>211</sup>At)-labeled phenylalanine: A preclinical study in glioma bearing miceTadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, et al.
Medical Physics|September 11, 2020
Development of high-resolution YAP(Ce) x-ray camera for the imaging of astatine-211(At-211) in small animalsKouhei Nakanishi, Seiichi Yamamoto, Tadashi Watabe, et al.
EJNMMI Radiopharmacy and Chemistry|August 22, 2021
One-pot and one-step automated radio-synthesis of [<sup>18</sup>F]AlF-FAPI-74 using a multi purpose synthesizer: a proof-of-concept experimentSadahiro Naka, Tadashi Watabe, Thomas Lindner, et al.
Pathology, Research and Practice|May 30, 2024
Expression of fibroblast activation protein in intrathoracic solitary fibrous tumorToru Kimura, Tadashi Watabe, Takahiro Matsui, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 19, 2025
An <sup>211</sup>At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanomaHiroyuki Suzuki, Saki Yamashita, Shoko Tanaka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 15, 2012
Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumorsMasahiro Yanagawa, Mitsuaki Tatsumi, Hiroshi Miyata, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2022
Targeted α-therapy using astatine (<sup>211</sup>At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compoundTadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2012
A novel PET index, 18F-FDG-11C-methionine uptake decoupling score, reflects glioma cell infiltrationManabu Kinoshita, Hideyuki Arita, Tetsu Goto, et al.
Transplantation|May 21, 2019
MHC-mismatched Allotransplantation of Induced Pluripotent Stem Cell-derived Cardiomyocyte Sheets to Improve Cardiac Function in a Primate Ischemic Cardiomyopathy ModelNoriyuki Kashiyama, Shigeru Miyagawa, Satsuki Fukushima, et al.
Japanese Journal of Clinical Oncology|December 9, 2023
Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patientsUkihide Tateishi, Koichiro Kimura, Junichi Tsuchiya, et al.
Pageof 19

Showing results (121-130 of 185) with videos related to

Sort By:
Pageof 19
Oncotarget|April 29, 2020
Targeted alpha therapy using astatine (<sup>211</sup>At)-labeled phenylalanine: A preclinical study in glioma bearing miceTadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, et al.
Medical Physics|September 11, 2020
Development of high-resolution YAP(Ce) x-ray camera for the imaging of astatine-211(At-211) in small animalsKouhei Nakanishi, Seiichi Yamamoto, Tadashi Watabe, et al.
EJNMMI Radiopharmacy and Chemistry|August 22, 2021
One-pot and one-step automated radio-synthesis of [<sup>18</sup>F]AlF-FAPI-74 using a multi purpose synthesizer: a proof-of-concept experimentSadahiro Naka, Tadashi Watabe, Thomas Lindner, et al.
Pathology, Research and Practice|May 30, 2024
Expression of fibroblast activation protein in intrathoracic solitary fibrous tumorToru Kimura, Tadashi Watabe, Takahiro Matsui, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 19, 2025
An <sup>211</sup>At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanomaHiroyuki Suzuki, Saki Yamashita, Shoko Tanaka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 15, 2012
Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumorsMasahiro Yanagawa, Mitsuaki Tatsumi, Hiroshi Miyata, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 7, 2022
Targeted α-therapy using astatine (<sup>211</sup>At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compoundTadashi Watabe, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2012
A novel PET index, 18F-FDG-11C-methionine uptake decoupling score, reflects glioma cell infiltrationManabu Kinoshita, Hideyuki Arita, Tetsu Goto, et al.
Transplantation|May 21, 2019
MHC-mismatched Allotransplantation of Induced Pluripotent Stem Cell-derived Cardiomyocyte Sheets to Improve Cardiac Function in a Primate Ischemic Cardiomyopathy ModelNoriyuki Kashiyama, Shigeru Miyagawa, Satsuki Fukushima, et al.
Japanese Journal of Clinical Oncology|December 9, 2023
Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patientsUkihide Tateishi, Koichiro Kimura, Junichi Tsuchiya, et al.
Pageof 19